AMCR vs CNTA · P/E 18, rev $23.51B vs $6.15B cap
Amcor PLC (AMCR) versus Centessa Pharmaceuticals PLC ADR (CNTA) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Centessa Pharmaceuticals PLC ADR (CNTA) is a biotechnology company listed on US.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported CNTA revenue for 2024-12-31 was $0. Net income was -$235.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. CNTA currently screens at market cap $6.15B.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. CNTA currently screens at market cap $6.15B.
Not investment advice. Open the AMCR and CNTA stock pages for the full models.
Not investment advice.